PABLO DE LA
CUEVA DOBAO
Profesor asociado de Ciencias de la Salud
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (27)
2024
-
Consensus Statement from the Spanish Academy of Dermatology and Venereology (AEDV) Psoriasis Working Group (SWG) and Pediatric Working Group (PWG) on the Management of Pediatric Psoriasis
Actas Dermo-Sifiliograficas
-
Efficacy of Risankizumab in Patients with Suboptimal Response or Failure to Ustekinumab: A Multicenter Retrospective Study in Spain
Dermatologic Therapy, Vol. 2024
-
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study
Actas Dermo-Sifiliograficas
-
Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 702-711
2023
-
Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study
JEADV Clinical Practice, Vol. 2, Núm. 3, pp. 488-501
-
Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 10, pp. 865-883
-
Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
Journal of Investigational Allergology and Clinical Immunology
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
2022
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2020
-
Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project
Reumatologia Clinica, Vol. 16, Núm. 1, pp. 24-31
-
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study
Dermatologic Therapy, Vol. 33, Núm. 6
2019
-
Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis
Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 7, pp. 1214-1223
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
Journal of Dermatological Treatment, Vol. 30, Núm. 5, pp. 461-465
2018
-
Management of Moderate to Severe Psoriasis in Routine Clinical Practice in Spanish Hospitals
Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 631-642
-
Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain
Rheumatology International, Vol. 38, Núm. 6, pp. 1115-1124
2017
-
Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España
Reumatologia Clinica, Vol. 13, Núm. 2, pp. 85-90
-
Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians
Journal of Dermatological Treatment, Vol. 28, Núm. 3, pp. 188-199
-
Psoriasis moderada. Propuesta de definición
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 10, pp. 911-917